Mitral valve geometry in paediatric rheumatic mitral regurgitation.
Yeong M, Silbery M, Finucane K, Wilson NJ, Gentles TL.
Pediatr Cardiol. 2015 Apr;36(4):827-34. doi: 10.1007/s00246-014-1085-1. Epub 2015 Jan 6.
Echocardiographic evaluation of non-surgically treated mild-to-moderate mitral dysfunction in patients undergoing aortic valve replacement.
Kim GS, Kim JB, Choo SJ, Chung CH, Lee JW, Jung SH.
J Cardiothorac Surg. 2019 Jun 20;14(1):112. doi: 10.1186/s13019-019-0934-7.
Clinical outcomes and management strategies for moderate aortic regurgitation in patients undergoing rheumatic mitral valve surgery.
Liu C, Liu Z, Liang JJ, Jia SH, Zhang MX, Liu PY, Wang MZ, Wang XL, Zhang HJ, Jiang WJ.
Sci Rep. 2026 Feb 3;16(1):7059. doi: 10.1038/s41598-026-37045-5.
[Clinical significance of aortic ring dilatation and changes in aortic root configuration in the pathogenesis of non-rheumatic aortic regurgitation].
Kashida M, Kuwako K, Yamaguchi T, Furuta S.
J Cardiol. 1989 Mar;19(1):177-85.
Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease.
Antunes MJ, Rodríguez-Palomares J, Prendergast B, De Bonis M, Rosenhek R, Al-Attar N, Barili F, Casselman F, Folliguet T, Iung B, Lancellotti P, Muneretto C, Obadia JF, Pierard L, Suwalski P, Zamorano P; ESC Working Groups of Cardiovascular Surgery and Valvular Heart Disease.
Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1022-1030. doi: 10.1093/ejcts/ezx279.
Effect of mitral regurgitation on stroke risk in patients with non-rheumatic atrial fibrillation.
Raposeiras-Roubín S, Domínguez-Erquicia P, Abu-Assi E, Ledo-Piñeiro A, González-García A, Iglesias-Otero C, García-Campo E, Íñiguez-Romo A.
Arch Cardiovasc Dis. 2022 Aug-Sep;115(8-9):448-456. doi: 10.1016/j.acvd.2022.05.006. Epub 2022 Aug 8.
Assessment of colour flow imaging in the grading of valvular regurgitation.
Galassi AR, Nihoyannopoulos P, Pupita G, Odawara H, Crea F, McKenna WJ.
Eur Heart J. 1990 Dec;11(12):1101-8. doi: 10.1093/oxfordjournals.eurheartj.a059649.
Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis.
Nascimento BR, Nunes MCP, da Silva JLP, Steer A, Engelman D, Okello E, Rwebembera J, Zuhlke L, Mirabel M, Nakitto M, Sarnacki R, Ribeiro ALP, Sable CA, Beaton AZ; (Gwoko Adunu pa Lutino) trial investigators.
Int J Cardiol. 2024 Mar 15;399:131662. doi: 10.1016/j.ijcard.2023.131662. Epub 2023 Dec 22.
Elevated Trans-mitral Pressure Gradient Predicts Surgery in Young People with Moderate-Severe Rheumatic Mitral Regurgitation.
Williamson JM, Whalley GA, Horton AE, Morris P, Remenyi B.
Pediatr Cardiol. 2025 Dec;46(8):2328-2338. doi: 10.1007/s00246-024-03660-0. Epub 2024 Oct 15.
Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease.
van Hagen IM, Thorne SA, Taha N, Youssef G, Elnagar A, Gabriel H, ElRakshy Y, Iung B, Johnson MR, Hall R, Roos-Hesselink JW; ROPAC Investigators and EORP Team.
Circulation. 2018 Feb 20;137(8):806-816. doi: 10.1161/CIRCULATIONAHA.117.032561.
